These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3026016)

  • 1. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms.
    Syriopoulou V; Bitsi M; Theodoridis C; Saroglou I; Krikos X; Tzanetou K
    Rev Infect Dis; 1986; 8 Suppl 5():S630-3. PubMed ID: 3026016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of sulbactam/ampicillin in screening and discriminative animal models of infection.
    English AR; Girard D; Cimochowski C; Faiella J; Retsema JA; Lynch JE
    Rev Infect Dis; 1986; 8 Suppl 5():S535-42. PubMed ID: 3026002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.
    Retsema JA; English AR; Girard A; Lynch JE; Anderson M; Brennan L; Cimochowski C; Faiella J; Norcia W; Sawyer P
    Rev Infect Dis; 1986; 8 Suppl 5():S528-34. PubMed ID: 3026001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
    Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
    Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind comparison of sulbactam/ampicillin and clindamycin for the treatment of aerobic and aerobic-anaerobic infections.
    Reinhardt JF; Johnston L; Ruane P; Johnson CC; Ingram-drake L; MacDonald K; Ward KW; Mathisen G; George WL; Finegold SM
    Rev Infect Dis; 1986; 8 Suppl 5():S569-75. PubMed ID: 3026005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
    Aronoff SC; Scoles PV; Makley JT; Jacobs MR; Blumer JL; Kalamchi A
    Rev Infect Dis; 1986; 8 Suppl 5():S639-43. PubMed ID: 3026018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulbactam/ampicillin in the treatment of acute epiglottitis in children.
    Wald E; Reilly JS; Bluestone CD; Chiponis D
    Rev Infect Dis; 1986; 8 Suppl 5():S617-9. PubMed ID: 3026014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of beta-lactamase-induced resistance in soft-tissue infections.
    Nichols RL; Smith JW; Adinolfi MF; Galli R; Vivoda LM
    Arch Surg; 1985 Jan; 120(1):36-42. PubMed ID: 2981523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sulbactam plus ampicillin in gynecologic infections.
    Giamarellou H; Trouvas G; Avlami A; Aravantinos D; Daikos GK
    Rev Infect Dis; 1986; 8 Suppl 5():S579-82. PubMed ID: 3026007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical evaluation of sulbactam/ampicillin in the treatment of pediatric infections.
    Huang LM; Lee CY; Lee MJ; Hsu CY; Liu CC; Hong JY; Chen JM
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(2):87-93. PubMed ID: 2637593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous sulbactam/ampicillin in the treatment of pediatric infections.
    Lee CY; Lin TY; Chu ML; Lee MJ; Hsu CY; Huang LM; Chen CM
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):179S-183S. PubMed ID: 2686918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections.
    Naber KG; Wittenberger R
    Rev Infect Dis; 1986; 8 Suppl 5():S604-8. PubMed ID: 3026011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical results of a multicenter study with sulbactam/ampicillin for the treatment of patients with lower respiratory and urinary tract infections.
    De Simone C; Chiodo F; Delia S; Pastore G; Scalise G; Sorice F; Tonietti G; Zanussi C; Paoloni M; Gargiulo M
    J Chemother; 1991 Oct; 3(5):321-7. PubMed ID: 1809811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients].
    Motohiro T; Sakata Y; Oda K; Aramaki M; Tanaka K; Koga T; Shimada Y; Fujimoto T; Yamashita F; Sakamoto H
    Jpn J Antibiot; 1989 Mar; 42(3):773-90. PubMed ID: 2664252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
    Galante D; Esposito S; Barba D; Ruffilli MP
    J Antimicrob Chemother; 1987 Apr; 19(4):527-32. PubMed ID: 3034850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of infections caused by ampicillin-resistant pathogens with a combination of ampicillin and CP-45,899.
    Plouffe JF
    Antimicrob Agents Chemother; 1982 Mar; 21(3):519-20. PubMed ID: 6285812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience with sulbactam/ampicillin in the pediatric field].
    Sekiguchi T; Okamoto T; Ohara K; Kohzan S; Nishimori M; Miyazaki M
    Jpn J Antibiot; 1989 Mar; 42(3):733-42. PubMed ID: 2746853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulbactam/ampicillin vs. chloramphenicol/ampicillin for the treatment of meningitis in infants and children.
    Rodríguez WJ; Khan WN; Puig J; Feris J; Harmon S; Gold BG; Ahmad S
    Rev Infect Dis; 1986; 8 Suppl 5():S620-9. PubMed ID: 3026015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use.
    Lees L; Milson JA; Knirsch AK; Greenhalgh K
    Rev Infect Dis; 1986; 8 Suppl 5():S644-50. PubMed ID: 3026019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections.
    Rev Infect Dis; 1986; 8 Suppl 5():S583-8. PubMed ID: 2879345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.